跳至主要内容
临床试验/EUCTR2021-001304-15-BE
EUCTR2021-001304-15-BE进行中(未招募)1 期

COVID-19: Study of the immune response in healthy volunteers after vaccination against SARS-CoV-2 (COVID19-VAX-AZG) and monitoring of breakthrough infections after booster vaccination (COVID19-VAX-DBI-AZG) and study of immune response after booster vaccination with Comirnaty Omicron XBB.1.5 (COVID19-VAX-XBB-AZG) - COVID19-VAX-AZG

vzw az groeninge0 个研究点目标入组 85 人开始时间: 2021年3月16日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
85

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • healthy volunteer older than 18 years
  • no infections at the time of vaccination and first blooddraw
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 80
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 5

排除标准

  • individuals infected with SARS-CoV-2 or have already been through a SARS-CoV-2 infection
  • individuals with primary immunedeficiency.
  • Individuals with immune modulating treatment
  • individuals with an anuto immune disease

研究者

发起方
vzw az groeninge

相似试验